Related Experiment Video
Updated: Nov 8, 2025

08:00
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
Published on: October 11, 2019
7.7K
TIMEx: tumor-immune microenvironment deconvolution web-portal for bulk transcriptomics using pan-cancer scRNA-seq
Mengyu Xie1, Kyubum Lee1, John H Lockhart2
1Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Bioinformatics (Oxford, England)
|April 26, 2021
Summary
We developed TIMEx, a new method to analyze immune cells in tumors using bulk transcriptomics. This tool helps understand cancer progression and treatment response by examining the tumor-immune microenvironment (TIME).
Area of Science:
- Cancer Biology
- Immunology
- Bioinformatics
Background:
- The tumor-immune microenvironment (TIME) is crucial for cancer progression, metastasis, and treatment efficacy.
- Understanding the cellular composition of the TIME is essential for developing targeted therapies.
Purpose of the Study:
- To introduce TIMEx, a novel deconvolution method for estimating infiltrating immune cells in bulk transcriptomics data.
- To provide a user-friendly web portal for evaluating TIMEx and comparing it with other deconvolution methods.
Main Methods:
- TIMEx utilizes pan-cancer single-cell RNA-seq signatures to deconvolute bulk transcriptomic profiles.
- The method specifically emphasizes the estimation of infiltrating immune cells within the TIME.
Main Results:
- TIMEx enables a more accurate assessment of immune cell infiltration from bulk RNA sequencing data.
- The developed web portal allows researchers to easily apply and compare deconvolution methods.
Conclusions:
- TIMEx is a valuable new tool for analyzing the tumor-immune microenvironment.
- The TIMEx web portal facilitates the evaluation and application of TIME deconvolution methods in cancer research.
Related Concept Videos
The Tumor Microenvironment
7.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
Tumor Immunotherapy
807
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
807

